Health Centers on the Front Lines: Be the Change: Black Cisgender and Trans Women, HIV Treatment, & PrEP
Resource updated 10/18/2023
Resource updated 10/18/2023
Resource updated 05/10/2023
Resource from the RWHAP Best Practices Compilation updated on 11/13/2023
Resource updated 05/15/2024
Resource updated 09/19/2023
Resource updated 09/14/2023
Resource from the RWHAP Best Practices Compilation updated on 11/01/2023
Resource updated 03/23/2023
RWHAP Technical Assistance Provider updated on 02/27/2024
Resource updated 09/19/2023
Resource updated 04/18/2024
Resource updated 06/18/2024
Resource updated 09/19/2023
Resource updated 03/04/2024
In a single-center restrospective cohort study, patients with extensive treatment experience and history of virologic failure and multi-drug resistance underwent simplification of ARV salvage regimens with a median pill burden reduction of six pills per day. This strategy led to high rates of virologic suppression.
Resource (Conference Presentation) updated 09/14/2023
The first long-acting injectable antiretroviral therapy (LAI ART) formulation was FDA-approved January 2021. Drawing on the Consolidated Framework on Implementation Research, this mixed methods study assessed knowledge, attitudes, practices, and perceived barriers and facilitators related to implementation of LAI ART in NYC among HIV clinic staff and people with HIV.
Resource (Conference Presentation) updated 09/14/2023
Description of how a modified Directly Observed Therapy (mDOT) program increased uptake of DOPT and the priority populations that experienced the uptake.
Resource (Conference Presentation) updated 09/14/2023
The objective of this study is to assess key stakeholders, including patients, for readiness to adopt a new standard of care. Because many people with HIV in Alabama experience low literacy, low income, and are racial minorities, data suggests they will experience greater barriers to healthcare information technology, like PROs and Telehealth.
Resource (Conference Presentation) updated 09/14/2023
Virginia quality improvement program that identifies access to medication barriers and provides emergency medication supplies to people with HIV if no timely access is secured.
Resource (Conference Presentation) updated 09/14/2023